Results 11 to 20 of about 78,708 (218)

Correction: A roadmap of priority evidence gaps for the co-implementation of malaria vaccines and perennial malaria chemoprevention [PDF]

open access: yesMalaria Journal
Jane Grant   +1 more
doaj   +2 more sources

Virosome-formulated Plasmodium falciparum AMA-1 & CSP derived peptides as malaria vaccine: randomized phase 1b trial in semi-immune adults & children. [PDF]

open access: yes, 2011
BACKGROUND\ud \ud This trial was conducted to evaluate the safety and immunogenicity of two virosome formulated malaria peptidomimetics derived from Plasmodium falciparum AMA-1 and CSP in malaria semi-immune adults and children.\ud \ud METHODS\ud \ud The
Cech, Patrick Georges   +12 more
core   +22 more sources

Malaria vaccines [PDF]

open access: yesMedical Journal of Australia, 2002
Malaria kills one child in Africa every 30 s. After summarising the burden of malaria, the life-cycle of this parasite in humans and female Anopheles mosquitoes is outlined. Important differences between natural immunity and that induced by current candidate vaccines are discussed.
Graham V, Brown, John C, Reeder
openaire   +5 more sources

Assessing the functional impact of PfRh5 genetic diversity on ex vivo erythrocyte invasion inhibition

open access: yesScientific Reports, 2021
The PfRh5-Basigin ligand–receptor interaction is an essential step in the merozoite invasion process and represents an attractive vaccine target. To reveal genotype–phenotype associations between naturally occurring allelic variants of PfRh5 and invasion
Adam J. Moore   +8 more
doaj   +1 more source

Structure-guided insights into potential function of novel genetic variants in the malaria vaccine candidate PfRh5

open access: yesScientific Reports, 2022
The recent stall in the global reduction of malaria deaths has made the development of a highly effective vaccine essential. A major challenge to developing an efficacious vaccine is the extensive diversity of Plasmodium falciparum antigens.
Khadidiatou Mangou   +22 more
doaj   +1 more source

A research agenda for malaria eradication: vaccines. [PDF]

open access: yesPLoS Medicine, 2011
Vaccines could be a crucial component of efforts to eradicate malaria. Current attempts to develop malaria vaccines are primarily focused on Plasmodium falciparum and are directed towards reducing morbidity and mortality.
malERA Consultative Group on Vaccines
doaj   +1 more source

RETRACTION: Top 100 cited articles on anosmia and COVID‐19: a bibliometric analysis

open access: yesWorld Journal of Otorhinolaryngology - Head and Neck Surgery, EarlyView., 2023
Retraction: Tan, DJY, Ko, TK. Top 100 cited articles on anosmia and COVID‐19: a bibliometric analysis. World J Otorhinolaryngol Head Neck Surg. 2023; 1–8. doi:10.1002/wjo2.125. The above article, published online on 28 July 2023 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the authors, the journal's Editor ...
Denise Jia Yun Tan, Tsz Ki Ko
wiley   +1 more source

Supra and subgingival application of antiseptics or antibiotics during periodontal therapy

open access: yesPeriodontology 2000, EarlyView., 2023
Abstract Periodontal diseases (gingivitis and periodontitis) are characterized by inflammatory processes which arise as a result of disruption of the balance in the oral ecosystem. According to the current S3 level clinical practice guidelines, therapy of patients with periodontitis involves a stepwise approach that includes the control of the patient ...
Elena Figuero   +5 more
wiley   +1 more source

Progress in the Development of Subunit Vaccines against Malaria

open access: yesVaccines, 2020
Malaria is a life-threatening disease and one of the main causes of morbidity and mortality in the human population. The disease also results in a major socio-economic burden.
Mariusz Skwarczynski   +8 more
doaj   +1 more source

Community perceptions of a malaria vaccine in the Kintampo districts of Ghana. [PDF]

open access: yes, 2013
BACKGROUND: Malaria remains the leading cause of morbidity and mortality in sub-Saharan Africa despite tools currently available for its control. Making malaria vaccine available for routine use will be a major hallmark, but its acceptance by community ...
A Bingham   +30 more
core   +2 more sources

Home - About - Disclaimer - Privacy